Factors Contributing to the Successful Tuberculosis Preventive Treatment in Latent Tuberculosis: Literature Review
DOI:
https://doi.org/10.36590/kepo.v6i2.1545Keywords:
therapy, tuberculosis, preventiveAbstract
In Indonesia, the coverage of tuberculosis preventive treatment in household contacts has not reached the national target (58%) of 2,6%. In the age group <5 years and other risk groups, the coverage was 5,1% and 3,1% , and the coverage in PLHIV was 6% with a national target of 50%. This literature review aimed to explore the factors that determine successful completion of TB preventive treatment. The literature review approach was conducted using databases from PubMed, Google Scholar, and ProQuest. Articles selected were full text, open access, between 2015 and 2025, and not a literature review, systematic review, or meta-analysis. From 487,952 articles based on keywords, 16 articles were selected that met the objectives and inclusion criteria of this study. The 16 articles were then entered into a matrix table to identify research results that were factors associated with the completion rate of tuberculosis preventive treatment (TPT) in patients with pulmonary tuberculosis. High TPT completion was supported by demographic factors, safe treatment regimens with minimal side effects, technology-based community approaches, improved access and adherence, tuberculosis education, social support, integrated health care systems and health policies.
Downloads
References
Alves, Y.M., Berra, T.Z., Jezus, S.V., Araújo, V.M.S., Pinheiro, J.S., Assis, L.B.O., Canelonez, M., Sacramento, D.S., Perez, F., Maciel, E.L.N., Arcêncio, R.A., 2024. Adherence to Short-Duration Treatment (3HP) for Latent Tuberculosis among International Migrants in Manaus, Amazonas: Evaluation of the Efficacy of Different Treatment Modalities. Microorganisms 12(8), 1-12. https://doi.org/10.3390/microorganisms12081629
Amuge, P.M., Ndekezi, D., Mugerwa, M., Bbuye, D., Rutebarika, D.A., Kizza, L., Namugwanya, C., Baita, A., Elyanu, P.J., Ntege, P.N., Kiragga, D., Birungi, C., Kekitiinwa, A.R., Kiragga, A., Sekadde, M.P., Salazar-Austin, N., Mandalakas, A.M., Musoke, P., 2024. Correction: Facilitators and Barriers to Initiating and Completing Tuberculosis Preventive Treatment Among Children and Adolescents Living with HIV in Uganda: A Qualitative Study of Adolescents, Caretakers and Health Workers. AIDS Research and Therapy 21(61), 1-9. https://doi.org/10.1186/s12981-024-00651-2
Apriani, L., Koesoemadinata, R.C., Bastos, M.L., Wulandari, D.A., Santoso, P., Alisjahbana, B., Rutherford, M.E., Hill, P.C., Benedetti, A., Menzies, D., Ruslami, R., 2022. Implementing The 4R and 9H Regimens for TB Preventive Treatment in Indonesia. International Journal of Tuberculosis and Lung Disease 26(2), 103–110. https://doi.org/10.5588/ijtld.21.0318
Bonnet, M., Vasiliu, A., Tchounga, B.K., Cuer, B., Fielding, K., Ssekyanzi, B., Tchakounte Youngui, B., Cohn, J., Dodd, P.J., Tiendrebeogo, G., Tchendjou, P., Simo, L., Okello, R.F., Kuate Kuate, A., Turyahabwe, S., Atwine, D., Graham, S.M., Casenghi, M., 2023. Effectiveness of a Community-Based Approach for the Investigation and Management of Children with Household Tuberculosis Contact in Cameroon and Uganda: A Cluster-Randomised Trial. Lancet Global Health 11(12), e1911–e1921. https://doi.org/10.1016/S2214-109X(23)00430-8
Bustamante-Rengifo, J.A., González-Salazar, L.Á., Osorio-Certuche, N., Bejarano-Lozano, Y., Cuevas, J.R.T., Astudillo-Hernández, M., Crespo-Ortiz, M.P., 2020. Prevalence of and Risk Factors Associated with Latent Tuberculosis Infection in a Latin American Region. PeerJ 8, 1–22. https://doi.org/10.7717/peerj.9429
Chen, H., Zhang, H., Cheng, J., Sun, D., Wang, Q., Wu, C., Liu, Y., Xia, Y., Xu, C., Zhang, C., 2024. Adherence to Preventive Treatment for Latent Tuberculosis Infection in Close Contacts of Pulmonary Tuberculosis Patients: A Cluster-Randomized Controlled Trial in China. International Journal of Infectious Disease 147, 1-7. https://doi.org/10.1016/j.ijid.2024.107196
Egere, U., Sillah, A., Togun, T., Kandeh, S., Cole, F., Jallow, A., Able-Thomas, A., Hoelscher, M., Heinrich, N., Hill, P.C., Kampmann, B., 2016. Isoniazid Preventive Treatment Among Child Contacts of Adults with Smear-Positive Tuberculosis in The Gambia. Public Health Action 6(4), 226–231. https://doi.org/10.5588/pha.16.0073
Felisia, F., Triasih, R., Nababan, B.W.Y., Sanjaya, G.Y., Dewi, S.C., Rahayu, E.S., Unwanah, L., Cros, P., Chan, G., 2023. High Tuberculosis Preventive Treatment Uptake and Completion Rates Using a Person-Centered Approach among Tuberculosis Household Contact in Yogyakarta. Tropical Medicine and Infectious Disease 8(12), 1-10. https://doi.org/10.3390/tropicalmed8120520
Gebreegziabher, S.B., Ashuro, A.A., Kumssa, T.H., Teferi, M.Y., Alemayue, E.A., Datiko, D.G., Yimer, S.A., Shagre, M.B., 2024. Tuberculosis Preventive Treatment Uptake Among People Living with HIV during COVID-19 Period in Addis Ababa, Ethiopia: A Retrospective Data Review. BMC Infectious Disease 24(449), 1–12. https://doi.org/10.1186/s12879-024-09403-z
Groot, L.M.D., Shearer, K., Sambani, C., Kaonga, E., Nyirenda, R., Mbendera, K., Golub, J.E., Hoffmann, C.J., Mulder, C., 2024. Health Care Providers Acceptance of Default Prescribing of TB Preventive Treatment for People Living with HIV in Malawi: A Qualitative Study. BMC Health Service Research 24(15), 1–9. https://doi.org/10.1186/s12913-023-10493-9
Ihesie, A., Chukwuogo, O., Eneogu, R., Daniel, O.K., Agbaje, A., Odume, B., Nongo, D., Ohikhuai, C., Kadiri-Eneh, N., Oyelaran, O., Obianeri, V., Gemert, W.V., Masini, E.O., D’auvergne, C., Ochuko, U., Anyaike, C., Olarewaju, S.O., 2024. Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients’ and Healthcare Workers’ Perspectives. Tropical Medicine and Infectious Disease 9(12), 1–15. https://doi.org/10.3390/tropicalmed9120301
Karbito, K., Susanto, H., Adi, M.S., Sulistiyani, S., Handayani, O.W.K., Sofro, M.A.U., 2022. Latent Tuberculosis Infection in Family Members in Household Contact with Active Tuberculosis Patients in Semarang City, Central Java, Indonesia. Journal of Public Health in Africa 13(2), 13–17. https://doi.org/10.4081/jphia.2022.2157
Kaswaswa, K., MacPherson, P., Kumwenda, M., Mpunga, J., Thindwa, D., Nliwasa, M., Mwapasa, M., Odland, J., Tomoka, T., Chipungu, G., Mukaka, M., Corbett, E.L., 2022. Effect of Patient-Delivered Household Contact Tracing and Prevention for Tuberculosis: A Household Cluster-Randomised Trial in Malawi. PLoS One 17(9), 1–15. https://doi.org/10.1371/journal.pone.0269219
Kay, A.W., Sandoval, M., Mtetwa, G., Mkhabela, M., Ndlovu, B., Devezin, T., Sikhondze, W., Vambe, D., Sibanda, J., Dube, G.S., Stevens, R.H., Lukhele, B., Mandalakas, A.M., 2022. Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting. Clinical Infectious Diseases 74(9), 1631–1638. https://doi.org/10.1093/cid/ciab652
[Kemenkes] Kementerian Kesehatan., 2024. Laporan Program Penanggulangan Tuberkulosis Tahun 2023. Kementerian Kesehatan RI, Jakarta.
Kiazyk, S., Ball, T., 2017. Latent Tuberculosis Infection: An Overview. Canada Communicable Disease Report 43(3), 62–66. https://doi.org/10.14745/ccdr.v43i34a01
Krishnamoorthy, Y., Ezhumalai, K., Murali, S., Rajaa, S., Jose, M., Sathishkumar, A., Soundappan, G., Horsburgh, C., Hochberg, N., Johnson, W.E., Knudsen, S., Salgame, P., Ellner, J., Babu, S.P., Sarkar, S., 2021. Prevalence and Risk Factors Associated with Latent Tuberculosis Infection Among Household Contacts of Smear Positive Pulmonary Tuberculosis Patients in South India. Tropical Medicine and International Health 26(12), 1645–1651. https://doi.org/10.1111/tmi.13693
Lee, S.H., 2016. Tuberculosis Infection and Latent Tuberculosis. Tuberculosis and Respiratory Diseases 79(4), 201–206. https://doi.org/10.4046/trd.2016.79.4.201
Matulyte, E., Kancauskiene, Z., Kausas, A., Urboniene, J., Lipnickiene, V., Kopeykiniene, J., Gudaitis, T., Raudonis, S., Danila, E., Costagliola, D., Matulionyte, R., 2023. Latent Tuberculosis Infection and Associated Risk Factors among People Living with HIV and HIV-Uninfected Individuals in Lithuania. Pathogens 12(8), 1–14. https://doi.org/10.3390/pathogens12080990
Mehtani, N.J., Puryear, S., Pham, P., Dooley, K.E., Shah, M., 2021. Infectious Diseases Learning Unit: Understanding Advances in the Treatment of Latent Tuberculosis Infection among People with Human Immunodeficiency Virus. Open Forum Infectious Diseases 8(8), 1–11. https://doi.org/10.1093/ofid/ofab319
Mirzazadeh, A., Kahn, J.G., Haddad, M.B., Hill, A.N., Marks, S.M., Readhead, A., Barry, P.M., Flood, J., Mermin, J.H., Shete, P.B., 2021. State-Level Prevalence Estimates of Latent Tuberculosis Infection in the United States by Medical Risk Factors, Demographic Characteristics and Nativity. PLoS One 16(4), 1–15. https://doi.org/10.1371/journal.pone.0249012
Mugenyi, L., Namuwenge, P.M., Ouma, S., Bakashaba, B., Nanfuka, M., Zech, J., Agaba, C., Ojok, A.M., Kaliba, F., Kato, J.B., Opito, R., Miya, Y., Katureebe, C., Hirsch-Moverman, Y., 2024. Isoniazid Preventive Therapy Completion Between July-September 2019: A Comparison Across HIV Differentiated Service Delivery Models in Uganda. PLoS One 19(1), 1–15. https://doi.org/10.1371/journal.pone.0296239
Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow, C.D., Shamseer, L., Tetzlaff, J.M., Akl, E.A., Brennan, S.E., Chou, R., Glanville, J., Grimshaw, J.M., Hróbjartsson, A., Lalu, M.M., Li, T., Loder, E.W., Mayo-Wilson, E., McDonald, S., McGuinness, L.A., Stewart, L.A., Thomas, J., Tricco, A.C., Welch, V.A., Whiting, P., Moher, D., 2021. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. Research Methods and Reporting 372, 1-9. https://doi.org/10.1136/bmj.n71
Rahman, M.T., Hossain, F., Banu, R.S., Islam, M.S., Alam, S., Faisel, A.J., Salim, H., Cordon, O., Suarez, P., Hussain, H., Roy, T., 2024. Uptake and Completion of Tuber Culosis Preventive Treatment Using 12-Dose, Weekly Isoniazid–Rifapentine Regimen in Bangladesh: A Community-Based Implementation Study. Tropical Medicine and Infectious Disease 9(1), 1-4. https://doi.org/10.3390/tropicalmed9010004
Semitala, F.C., Kadota, J.L., Musinguzi, A., Nabunje, J., Welishe, F., Nakitende, A., Akello, L., Bishop, O., Patel, D., Sammann, A., Nahid, P., Belknap, R., Kamya, M.R., Handley, M.A., Phillips, P.P.J., Katahoire, A., Berger, C.A., Kiwanuka, N., Katamba, A., Dowdy, D.W., Cattamanchi, A., 2021. Completion of Isoniazid–Rifapentine (3HP) for Tuberculosis Prevention Among People Living with HIV: Interim Analysis of A Hybrid Type 3 Effectiveness–Implementation Randomized Trial. PLoS Med 18(12), 1–13. https://doi.org/10.1371/journal.pmed.1003875
Tegegnework, A.Z., Aemiro, M.T., Bilchut, A.H., Mekuria, A.D., Yehualashet, S.S., 2024. Completion of Tuberculosis Preventive Therapy and Associated Factors Among Clients on Antiretroviral Therapy at Debre Berhan Town Health Facilities, North Shoa Zone, Ethiopia. AIDS Research and Therapy 21(44), 1–6. https://doi.org/10.1186/s12981-024-00629-0
[WHO] World Health Organization., 2024. Global Tuberculosis Report 2024. World Health Organization, Geneva.
